MétaCan
Menu
← Back to cohort

PD20-06 EVALUATION OF VULVAR HEALTH FROM PHOTOGRAPHS

2019· article· en· W2941783318 on OpenAlexaboutno aff
Irwin Goldstein, James A. Simon, Andrew M. Kaunitz, Corrado Altomare, Yuki Yoshida, Julie Zhu, Samuel Schaffer, Graziella Soulban

Bibliographic record

VenueThe Journal of Urology · 2019
Typearticle
Languageen
FieldMedicine
TopicCervical Cancer and HPV Research
Canadian institutionsnot available
Fundersnot available
KeywordsMedicinePlaceboClinical trialGynecologyAlternative medicineInternal medicine

Abstract

fetched live from OpenAlex

You have accessJournal of UrologySexual Function/Dysfunction: Female (PD20)1 Apr 2019PD20-06 EVALUATION OF VULVAR HEALTH FROM PHOTOGRAPHS Irwin Goldstein*, James Simon, Andrew Kaunitz, Corrado Altomare, Yuki Yoshida, Julie Zhu, Samuel Schaffer, and Graziella Soulban Irwin Goldstein*Irwin Goldstein* More articles by this author , James SimonJames Simon More articles by this author , Andrew KaunitzAndrew Kaunitz More articles by this author , Corrado AltomareCorrado Altomare More articles by this author , Yuki YoshidaYuki Yoshida More articles by this author , Julie ZhuJulie Zhu More articles by this author , Samuel SchafferSamuel Schaffer More articles by this author , and Graziella SoulbanGraziella Soulban More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000555738.52489.74AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: A multicenter, randomized, double-blind, placebo-controlled trial assessed efficacy and safety of ospemifene 60 mg QD in 631 postmenopausal women (age 40-80) with moderate to severe vaginal dryness as the most bothersome symptom (MBS) of VVA due to menopause. The primary aim was validation of vulvar photography as an objective measure of vulvar health. The secondary aim was to compare Vulvar Imaging Assessment Scale (VIAS) data from photographs to visual study measures assessed by investigators at each site, including Vaginal Health Index (VHI), and Vulvar Health Index (VuHI). METHODS: Photographs from sites were sent to a central monitoring system, uploaded to a dedicated website and accessed by three expert reviewers who independently assessed vulvar blinded images using a calibrated standardized monitor. Photographs were graded (none/mild/moderate/severe 0-3, cannot evaluate) for 9 criteria: labia majora loss, labia minora loss, clitoris size, urethral glans prominence, introital stenosis, introital pallor, introital erythema, introital moisture, mucosal inflammation. VHI evaluated vaginal fluid secretion, overall elasticity, pH, condition of epithelial mucosa, moisture as normal/mild/moderate/severe. VuHI rated vulvar appearance of labia majora, labia minora, clitoris, introitus appearance/elasticity, color, discomfort, pain as normal/mild/moderate/severe. RESULTS: 316 ospemifene and 315 placebo subjects were randomized. VIAS, range 0-27, was graded at baseline (ospemifene, 13.8; placebo, 14.1) and week 12, lower values showing better vulvovaginal health. The difference between treatment groups in least square (LS) mean change from baseline was -1.0 (p = 0.0118) at week 12, representing a greater decrease in the ospemifene group relative to placebo. VHI, range 5-25, was graded at baseline (13.0 in both groups) and week 12, higher values being better vaginal health. The difference between groups in LS mean change from baseline was week 4: 2.5, week 8: 2.9, week 12: 2.8 (all p < 0.0001), with greater increases in the ospemifene group. VuHI, range 0-21, was graded at baseline and week 12, with lower values indicating better vulvar health. The mean VuHI total score at baseline (ospemifene, 7.6; placebo, 7.7) was similar in both groups. The difference between groups in LS mean change from baseline was -0.8 (p = 0.0002) at week 4 and -1.1 to -1.2 at weeks 8 and 12 (both p < 0.0001), a statistically significant decrease in the ospemifene group compared to placebo. CONCLUSIONS: Evaluation of vulvar health from photograph images to assess MBS of menopausal women should be considered for future trials. Source of Funding: Duchesnay, Inc. San Diego, CA; Washington, DC; Jacksonsille, FL; Florham Park, FL; Florham Park, NJ; Blainville, Canada© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e379-e379 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Irwin Goldstein* More articles by this author James Simon More articles by this author Andrew Kaunitz More articles by this author Corrado Altomare More articles by this author Yuki Yoshida More articles by this author Julie Zhu More articles by this author Samuel Schaffer More articles by this author Graziella Soulban More articles by this author Expand All Advertisement PDF downloadLoading ...

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.390
Threshold uncertainty score0.870

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.3900.083

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.391
Teacher spread0.335 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of Urology→Same topicCervical Cancer and HPV Research→French-language works237,207→